Drug of choice for rapid cyclers in manic-depressive psychosis is:
**Core Concept**
In the management of bipolar disorder, particularly in rapid cyclers, the goal is to stabilize mood and prevent frequent episodes of mania or depression. Rapid cyclers are characterized by four or more mood episodes in a year, with at least one episode of mania or hypomania.
**Why the Correct Answer is Right**
Lithium is the drug of choice for rapid cyclers in manic-depressive psychosis due to its mood-stabilizing properties. It has a unique mechanism of action, which involves the inhibition of inositol monophosphate, a key enzyme in the phosphatidylinositol signaling pathway. This leads to a decrease in the activity of various neurotransmitter systems, including dopamine, serotonin, and norepinephrine, thereby exerting a stabilizing effect on mood.
**Why Each Wrong Option is Incorrect**
**Option A:** Haloperidol is a typical antipsychotic that can be used to treat acute manic episodes but is not the drug of choice for rapid cyclers. It has a high risk of extrapyramidal side effects and can worsen tardive dyskinesia.
**Option B:** Valproate is an anticonvulsant that can also be used as a mood stabilizer in bipolar disorder. However, it is not the first-line treatment for rapid cyclers and has a higher risk of hepatotoxicity compared to lithium.
**Option C:** Carbamazepine is another anticonvulsant that has mood-stabilizing properties, but it is not the preferred treatment for rapid cyclers due to its potential for sedation and cognitive impairment.
**Clinical Pearl / High-Yield Fact**
Rapid cyclers are a challenging group to manage, and the use of multiple medications, including mood stabilizers and antipsychotics, is often necessary to achieve stability. Lithium's efficacy in this population is well-established, and it is considered a cornerstone of treatment.
**Correct Answer: C. Carbamazepine**